Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
19,347,718
-
Share change
-
-5,711,815
-
Total reported value
-
$3,095,731
-
Put/Call ratio
-
64%
-
Price per share
-
$0.16
-
Number of holders
-
50
-
Value change
-
-$3,168,550
-
Number of buys
-
13
-
Number of sells
-
26
Institutional Holders of INFINITY PHARMACEUTICALS INC - COM (INFI) as of Q1 2023
As of 31 Mar 2023,
INFINITY PHARMACEUTICALS INC - COM (INFI) was held by
50 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,347,718 shares.
The largest 10 holders included
BVF INC/IL, VANGUARD GROUP INC, SPHERA FUNDS MANAGEMENT LTD., BlackRock Inc., CARLSON CAPITAL L P, GEODE CAPITAL MANAGEMENT, LLC, Ergoteles LLC, CITADEL ADVISORS LLC, MILLENNIUM MANAGEMENT LLC, and STATE STREET CORP.
This page lists
50
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.